APP and Alzheimer disease: In support of these proposed mechanisms, microglial activation has been linked to increased synaptic loss and neurodegeneration in AD[2,24,27], and pharmacologic inhibition of microglial proliferation in the APP/PS1 mouse effectively shifted microglia to an anti-inflammatory phenotype that was associated with decreased synaptic degeneration and improved memory[28].